Success Metrics

Clinical Success Rate

50.0%

Based on 1 completed trials

Completion Rate

50%(1/2)

Active Trials

1(14%)

Results Posted

0%(0 trials)

Terminated

1(14%)

Phase Distribution

Ph phase_2

14%

Ph phase_1

14%

Ph not_applicable

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

Phase 2Efficacy & side effects

1(25.0%)

N/ANon-phased studies

2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(5)

Completed(1)

Terminated(1)

Detailed Status

Not yet recruiting3

Recruiting1

Terminated1

Enrolling by invitation1

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 2

Trials by Phase

Phase 11 (25.0%)

Phase 21 (25.0%)

N/A2 (50.0%)

Trials by Status

recruiting114%

terminated114%

enrolling_by_invitation114%

completed114%

not_yet_recruiting343%

Recent Activity

1 active trials

Showing 5 of 7

recruitingnot_applicable

Central Vein Sign in Multiple Sclerosis Extension Study

NCT07424027

completednot_applicable

Dynamic Measurement of Cerebrospinal Fluid in Healthy Subjects: Pilot Study

NCT06743347

not_yet_recruitingphase_2

Biomarkers of the Locus Coeruleus Nucleus: Links With Early Tau Pathology, Cognition and Alzheimer's Disease Risk

NCT07007208

not_yet_recruiting

National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis

NCT06876064

enrolling_by_invitationphase_1

Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma

NCT06896110

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT07424027Not Applicable

Central Vein Sign in Multiple Sclerosis Extension Study

Recruiting

NCT06743347Not Applicable

Dynamic Measurement of Cerebrospinal Fluid in Healthy Subjects: Pilot Study

Completed

NCT07007208Phase 2

Biomarkers of the Locus Coeruleus Nucleus: Links With Early Tau Pathology, Cognition and Alzheimer's Disease Risk

Not Yet Recruiting

NCT06876064

National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis

Not Yet Recruiting

NCT06896110Phase 1

Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma

Enrolling By Invitation

NCT06617624

Magnetic Resonance Imaging Development for High Resolution Atrial Structural and Functional Characterization

Not Yet Recruiting

NCT02550366

Accelerated Contrast-Enhanced High Resolution Whole Heart Cardiac MRI

Terminated

All 7 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 7